Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Métodos Terapêuticos e Terapias MTCI
Base de dados
Ano de publicação
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
PLoS One ; 18(3): e0283674, 2023.
Artigo em Inglês | MEDLINE | ID: mdl-37000776

RESUMO

The overconsumption and inappropriate use of antibiotics is escalating antibiotic resistance development, which is now one of the 10 top threats to global health. Introducing antibiotics with a novel mode of action into clinical use is urgently needed to address this issue. Deliberately inducing aggregation of target proteins and disrupting protein homeostasis in bacteria via amyloidogenic peptides, also called Pept-ins (from peptide interferors), can be lethal to bacteria and shows considerable promise as a novel antibiotic strategy. However, the translation of Pept-ins into the clinic requires further investigation into their mechanism of action and improvement of their therapeutic window. Therefore, we performed systematic structure modifications of 2 previously discovered Pept-ins, resulting in 179 derivatives, and investigated the corresponding impact on antimicrobial potency, cellular accumulation, and ability to induce protein aggregation in bacteria, in vitro aggregation property, and toxicity on mammalian cells. Our results show that both Pept-in accumulation and aggregation of target proteins in bacteria are requisite for Pept-in mediated antimicrobial activity. Improvement of these two parameters can be achieved via increasing the number of arginine residues, increasing Pept-in aggregation propensity, optimizing the aggregate core structure, adopting ß-turn linkers, or forming a disulphide bond. Correspondingly, improvement of these two parameters can enhance Pept-in antimicrobial efficacy against wildtype E. coli BL21 used in the laboratory as well as clinically isolated multidrug-resistant strain E. coli ATCC, A. baumannii, and K. pneumoniae.


Assuntos
Anti-Infecciosos , Escherichia coli , Animais , Anti-Infecciosos/farmacologia , Antibacterianos/farmacologia , Antibacterianos/química , Relação Estrutura-Atividade , Bactérias , Klebsiella pneumoniae , Testes de Sensibilidade Microbiana , Mamíferos
2.
Sci Rep ; 6: 20877, 2016 Feb 12.
Artigo em Inglês | MEDLINE | ID: mdl-26869068

RESUMO

Hexanucleotide repeat expansions in C9orf72 are the most common cause of amyotrophic lateral sclerosis (ALS) and frontotemporal degeneration (FTD) (c9ALS/FTD). Unconventional translation of these repeats produces dipeptide repeat proteins (DPRs) that may cause neurodegeneration. We performed a modifier screen in Drosophila and discovered a critical role for importins and exportins, Ran-GTP cycle regulators, nuclear pore components, and arginine methylases in mediating DPR toxicity. These findings provide evidence for an important role for nucleocytoplasmic transport in the pathogenic mechanism of c9ALS/FTD.


Assuntos
Esclerose Lateral Amiotrófica/genética , Núcleo Celular/metabolismo , Dipeptídeos/química , Drosophila melanogaster/genética , Demência Frontotemporal/genética , Genes de Insetos , Testes Genéticos , Sequências Repetitivas de Aminoácidos , Transporte Ativo do Núcleo Celular/genética , Animais , Arginina/metabolismo , Modelos Animais de Doenças , Olho/patologia , Células HeLa , Humanos , Metilação , Interferência de RNA
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA